Rapidly acting antitumoral antiangiogenic therapies

Alberto D'Onofrio

Research output: Contribution to journalArticlepeer-review


We deal with a biophysical description of antitumor antiangiogenic therapies. In particular, by means of some simple models, we study the possible effects of the delay between the drug consumption by endothelial cells and their death on the outcome of the therapy. We have found that this time lag implies an increase in the minimal dose guaranteeing tumor eradication and, if the delay is greater than a meaningful threshold, it may preclude the total regression. These results might be of interest in better understanding the causes underlying the contradictory literature on the clinical trials of antiangiogenic therapies.

Original languageEnglish
Article number031920
JournalPhysical Review E - Statistical, Nonlinear, and Soft Matter Physics
Issue number3
Publication statusPublished - Sep 20 2007

ASJC Scopus subject areas

  • Mathematical Physics
  • Physics and Astronomy(all)
  • Condensed Matter Physics
  • Statistical and Nonlinear Physics


Dive into the research topics of 'Rapidly acting antitumoral antiangiogenic therapies'. Together they form a unique fingerprint.

Cite this